Alexander Siebenhüner

3.5k total citations
44 papers, 1.1k citations indexed

About

Alexander Siebenhüner is a scholar working on Oncology, Epidemiology and Surgery. According to data from OpenAlex, Alexander Siebenhüner has authored 44 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Oncology, 15 papers in Epidemiology and 10 papers in Surgery. Recurrent topics in Alexander Siebenhüner's work include Neuroendocrine Tumor Research Advances (10 papers), Colorectal Cancer Treatments and Studies (9 papers) and Pancreatic and Hepatic Oncology Research (7 papers). Alexander Siebenhüner is often cited by papers focused on Neuroendocrine Tumor Research Advances (10 papers), Colorectal Cancer Treatments and Studies (9 papers) and Pancreatic and Hepatic Oncology Research (7 papers). Alexander Siebenhüner collaborates with scholars based in Switzerland, Germany and Austria. Alexander Siebenhüner's co-authors include Thomas Winder, René Warschkow, Ulrich Güller, Markus Borner, Sara De Dosso, Christoforos Astaras, Roger Stupp, Petr Szturz, Panagiotis Samaras and Niloy R. Datta and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Annals of Surgery.

In The Last Decade

Alexander Siebenhüner

39 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alexander Siebenhüner Switzerland 13 574 356 210 198 159 44 1.1k
Sukhbinder Dhesy‐Thind Canada 17 842 1.5× 162 0.5× 173 0.8× 263 1.3× 156 1.0× 50 1.3k
Haruo Miwa Japan 16 296 0.5× 169 0.5× 147 0.7× 191 1.0× 545 3.4× 79 1.1k
Huanhuan Sun China 19 453 0.8× 120 0.3× 85 0.4× 250 1.3× 270 1.7× 35 981
Radek Kučera Czechia 19 309 0.5× 94 0.3× 105 0.5× 270 1.4× 281 1.8× 94 1.0k
Yung‐Chang Lin Taiwan 19 664 1.2× 139 0.4× 533 2.5× 167 0.8× 273 1.7× 49 1.3k
Jiajia Zhang United States 16 867 1.5× 111 0.3× 283 1.3× 319 1.6× 250 1.6× 57 1.2k
Majella B. Doyle United States 15 361 0.6× 496 1.4× 79 0.4× 221 1.1× 121 0.8× 38 1.0k
Nikolaos Charalampakis Greece 12 511 0.9× 213 0.6× 163 0.8× 305 1.5× 270 1.7× 42 988
Katrien Vandecasteele Belgium 19 290 0.5× 211 0.6× 154 0.7× 477 2.4× 129 0.8× 57 1.1k
Nikolaos Thomakos Greece 20 350 0.6× 222 0.6× 197 0.9× 156 0.8× 259 1.6× 127 1.4k

Countries citing papers authored by Alexander Siebenhüner

Since Specialization
Citations

This map shows the geographic impact of Alexander Siebenhüner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander Siebenhüner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander Siebenhüner more than expected).

Fields of papers citing papers by Alexander Siebenhüner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexander Siebenhüner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander Siebenhüner. The network helps show where Alexander Siebenhüner may publish in the future.

Co-authorship network of co-authors of Alexander Siebenhüner

This figure shows the co-authorship network connecting the top 25 collaborators of Alexander Siebenhüner. A scholar is included among the top collaborators of Alexander Siebenhüner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexander Siebenhüner. Alexander Siebenhüner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
López‐Alcalde, Jesús, et al.. (2023). Acupuncture for the prevention of chemotherapy‐induced nausea and vomiting in cancer patients: A systematic review and meta‐analysis. Cancer Medicine. 12(11). 12504–12517. 18 indexed citations
3.
Wirtz, Stefan, Klaus Weber, Axel Denz, et al.. (2023). Colon Cancer Microbiome Landscaping: Differences in Right- and Left-Sided Colon Cancer and a Tumor Microbiome-Ileal Microbiome Association. International Journal of Molecular Sciences. 24(4). 3265–3265. 22 indexed citations
4.
Krug, Sebastian, Jens Walldorf, Philipp A. Reuken, et al.. (2022). The Patient’s Point of View: COVID-19 and Neuroendocrine Tumor Disease. Cancers. 14(3). 613–613. 2 indexed citations
7.
Langheinrich, Melanie, Alexander Siebenhüner, Vera Schellerer, et al.. (2022). NCR, an Inflammation and Nutrition Related Blood-Based Marker in Colon Cancer Patients: A New Promising Biomarker to Predict Outcome. Diagnostics. 13(1). 116–116. 2 indexed citations
8.
Siebenhüner, Alexander, Sara De Dosso, Daniel Helbling, et al.. (2021). Advanced Gastric Cancer: Current Treatment Landscape and a Future Outlook for Sequential and Personalized Guide: Swiss Expert Statement Article. Oncology Research and Treatment. 44(9). 485–494. 21 indexed citations
9.
Siebenhüner, Alexander, Michael Mikolasek, Claudia M. Witt, & Jürgen Barth. (2021). Improvements in Health Might Contradict Adherence to Mobile Health Interventions: Findings from a Self-Care Cancer App Study. The Journal of Alternative and Complementary Medicine. 27(S1). S–115. 12 indexed citations
10.
Dosso, Sara De, Alexander Siebenhüner, Thomas Winder, et al.. (2021). Treatment landscape of metastatic pancreatic cancer. Cancer Treatment Reviews. 96. 102180–102180. 120 indexed citations
11.
Unseld, Matthias, Jelena Belic, Qing Zhou, et al.. (2020). A higher ctDNA fraction decreases survival in regorafenib‐treated metastatic colorectal cancer patients. Results from the regorafenib's liquid biopsy translational biomarker phase II pilot study. International Journal of Cancer. 148(6). 1452–1461. 12 indexed citations
12.
Malka, David, Alexander Siebenhüner, Joachim C. Mertens, & Peter Schirmacher. (2020). The Importance of Molecular Testing in the Treatment of Cholangiocarcinoma. SHILAP Revista de lepidopterología. 2 indexed citations
14.
Lautenschlager, S., Nicolas Fournier, Luc Biedermann, et al.. (2020). The Influence of Breastfeeding, Cesarean Section, Pet Animals, and Urbanization on the Development of Inflammatory Bowel Disease: Data from the Swiss IBD Cohort Study. Inflammatory Intestinal Diseases. 5(4). 170–179. 2 indexed citations
15.
Schreiner, Philipp, Bahtiyar Yılmaz, Jean‐Benoît Rossel, et al.. (2019). Vegetarian or gluten‐free diets in patients with inflammatory bowel disease are associated with lower psychological well‐being and a different gut microbiota, but no beneficial effects on the course of the disease. United European Gastroenterology Journal. 7(6). 767–781. 74 indexed citations
16.
Fabris, Luca, María J. Perugorria, Joachim C. Mertens, et al.. (2019). The tumour microenvironment and immune milieu of cholangiocarcinoma. Liver International. 39(S1). 63–78. 122 indexed citations
17.
Schreiner, Philipp, Bahtiyar Yılmaz, Yannick Franc, et al.. (2018). P855 Vegetarian and gluten-free diet in patients with IBD—associated with a different microbiota compared with omnivore IBD patients. Journal of Crohn s and Colitis. 12(supplement_1). S549–S549. 2 indexed citations
18.
Britschgi, Christian, Markus Rechsteiner, Nadejda Valtcheva, et al.. (2017). Implications of routine NGS testing for daily clinical practice – the Zurich experience with the OFA panel. Annals of Oncology. 28. vii15–vii15. 1 indexed citations
20.
Meyer, Norbert, et al.. (2014). Differential serum protein markers and the clinical severity of asthma. Journal of Asthma and Allergy. 7. 67–67. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026